SuperworthCNS Pharmaceuticals market cap CNSP
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $7.3M
- Highest close in our data
- $82.1M
- Jan 2020
CNS Pharmaceuticals is worth $7.3M at the close on Oct 23, 2026, at $4.97 a share.
That is up 53% over the last year and down 81% over five years.
Its highest close in our data was $82.1M in Jan 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $7.3M | $1.4M | $8.5M | +90% |
| 2025 | $3.8M | $1.5M | $8M | −41% |
| 2024 | $6.5M | $26.7K | $7.2M | −3% |
| 2023 | $6.7M | $1.3M | $14M | +108% |
| 2022 | $3.2M | $2.9M | $21.4M | −84% |
| 2021 | $19.6M | $19.6M | $77.9M | −34% |
| 2020 | $29.6M | $27.7M | $82.1M | −54% |
| 2019 | $64.2M | $64.2M | $64.2M | n/a |
Against its peers
Companies in Healthcare nearest CNS Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| CNSPCNS Pharmaceuticals | $7.3M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $52.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on CNS Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.